🚀
Enjoy a 7-Day Free Trial Thru May 02, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Caribou Biosciences Inc (NAS:CRBU)
News
Caribou Biosciences Inc
NAS
:CRBU (USA) Â
Ordinary Shares
$ 3.75
-0.1001 (-2.6%)
11:49 AM EST
P/E:
At Loss
P/B:
0.90
Market Cap:
$ 338.67M
Enterprise V:
$ 45.99M
Volume:
585.97K
Avg Vol (2M):
1.75M
Warning! GuruFocus detected 1 Severe warning sign with CRBU.
Try a 7-Day Free Trial
to check it out.
Volume:
585.97K
Market Cap $:
338.67M
PE Ratio:
At Loss
Avg Vol (2M):
1.75M
Enterprise Value $:
45.99M
PB Ratio:
0.90
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Caribou Biosciences Inc (NAS:CRBU) Stock News, Headlines & Updates
Caribou Biosciences Inc Stock News from GuruFocus
Total 74
1
2
Apr 24, 2024
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Marketwired
•
9:00am
Apr 15, 2024
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Marketwired
•
8:00am
Feb 24, 2024
Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio
GuruFocus Research
•
10:25pm
Feb 14, 2024
Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio
GuruFocus Research
•
2:02pm
Jan 07, 2024
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
GlobeNewswire
•
11:00am
Nov 06, 2023
Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board
Marketwired
•
8:00am
Nov 01, 2023
Caribou Biosciences to Participate in Upcoming Investor Conferences
Marketwired
•
4:00pm
Oct 18, 2023
Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Marketwired
•
7:00am
Sep 27, 2023
Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer
Marketwired
•
7:00am
Aug 29, 2023
Caribou Biosciences to Participate in Upcoming Investor Conferences
Marketwired
•
3:00pm
Aug 08, 2023
Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Marketwired
•
3:00pm
Jul 14, 2023
Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering
GlobeNewswire
•
11:00pm
Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering
Marketwired
•
11:00pm
Jul 13, 2023
Caribou Biosciences Announces Proposed Public Offering of Common Stock
Marketwired
•
4:00pm
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
Marketwired
•
4:00pm
Jul 06, 2023
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
Marketwired
•
7:00am
Jun 22, 2023
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Business Wire
•
11:00pm
Mar 02, 2023
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
sperokesalga
•
8:00pm
Feb 28, 2023
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Caribou Biosciences, Inc. (NASDAQ: CRBU) Shareholders
sperokesalga
•
3:00pm
Bronstein, Gewirtz & Grossman, LLC Notifies Caribou Biosciences, Inc. (CRBU) Investors of Class Action and to Actively Participate
sperokesalga
•
9:00am
Caribou Biosciences, Inc.: Please contact the Portnoy Law Firm to recover your losses; April 11, 2023. deadline
sperokesalga
•
8:00pm
Caribou Biosciences, Inc. (CRBU) Class Action Alert: Contact Robbins LLP for Information Regarding Class Action Against Caribou Biosciences, Inc.
sperokesalga
•
6:00pm
Feb 27, 2023
ROSEN, A LEADING NATIONAL FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CRBU
sperokesalga
•
1:00pm
Feb 25, 2023
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
sperokesalga
•
8:00pm
Feb 22, 2023
ROSEN, LEADING INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CRBU
sperokesalga
•
1:00pm
Feb 21, 2023
Bronstein, Gewirtz & Grossman, LLC Notifies Caribou Biosciences, Inc. (CRBU) Investors of Class Action and to Actively Participate
sperokesalga
•
10:00am
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – CRBU
sperokesalga
•
6:00pm
Feb 20, 2023
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
sperokesalga
•
8:00pm
Feb 17, 2023
Caribou Biosciences, Inc.: Please contact the Portnoy Law Firm to recover your losses; April 11, 2023 deadline
sperokesalga
•
1:00pm
Caribou Biosciences, Inc. (CRBU) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Caribou Biosciences, Inc.
sperokesalga
•
11:00am
Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
sperokesalga
•
8:00am
Feb 16, 2023
CRBU INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CRBU
sperokesalga
•
2:00pm
Feb 15, 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – CRBU
sperokesalga
•
6:00pm
Feb 14, 2023
CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. (NASDAQ: CRBU)
sperokesalga
•
3:00pm
Caribou Biosciences, Inc.: Please contact the Portnoy Law Firm to recover your losses; April 11, 2023 deadline
sperokesalga
•
10:00pm
Feb 11, 2023
CRBU Class Action Lawsuit Announced: Johnson Fistel Encourages Shareholders to Submit Their Caribou Biosciences Information
sperokesalga
•
11:00am
Pomerantz Law Firm Announces the Filing of a Class Action Against Caribou Biosciences, Inc. and Certain Officers and Directors – CRBU
sperokesalga
•
9:00pm
Feb 01, 2023
Caribou Biosciences to Participate in Upcoming Investor Conferences
Stock market mentor
•
4:00pm
Jan 03, 2023
Caribou Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference
Stock market mentor
•
4:04pm
Jan 02, 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caribou Biosciences, Inc. - CRBU
Tiesvg
•
9:00pm
Total 74
1
2
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news